Angiogenic factors as diagnostic tests for preeclampsia: A performance comparison between two commercial immunoassays

American Journal of Obstetrics and Gynecology

Volumn 205, Issue 5, 2011, Pages 469.e1-469.e8

  Benton, Samantha J ^a,b   Hu, Yuxiang ^a,b   Xie, Fang ^a,b   Kupfer, Kenneth ^c   Lee, Seok Won ^c   Magee, Laura A ^a,b   Von Dadelszen, Peter ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Alere San Diego   (United States)

Author keywords

angiogenesis; biomarker; diagnostic test; placental growth factor (PlGF); preeclampsia; soluble Fms like tyrosine kinase 1 (sFlt 1)

Indexed keywords

ANGIOGENIC FACTOR; PLACENTAL GROWTH FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; ELECSYS SOLUBLE FMS LIKE TYROSINE KINASE 1 PLACENTAL GROWTH FACTOR RATIO ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; PREECLAMPSIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; TRIAGE PLACENTAL GROWTH FACTOR ASSAY;

EID: 80255122679     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.06.058     Document Type: Article

References (29)

1. E.A. Steegers, P. von Dadelszen, J.J. Duvvekot, and R. Pijnenborg Preeclampsia Lancet 376 2010 631 644
2. B.M. Sibai, and C.L. Stella Diagnosis and management of atypical preeclampsia-eclampsia Am J Obstet Gynecol 200 2009 481.e1 481.e6
3. B.M. Sibai Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count Obstet Gynecol 103 2004 981 991 (Pubitemid 40459001)
4. P. von Dadelszen, B. Payne, and J. Li Prediction of adverse maternal outcomes in preeclampsia: development and validation of the fullPIERS model Lancet 377 2011 219 227
5. K.A. Douglas, and C.W.G. Redman Eclampsia in the United Kingdom BMJ 309 1994 1395 1400 (Pubitemid 24351401)
6. L.A. Magee, P. von Dadelszen, and S. Chan The control of hypertension in pregnancy study pilot trial BJOG 114 2007 770.e13 770.e20
7. B. Sibai Imitators of severe preeclampsia Semin Perinatol 33 2009 196 205
8. S. Maynard, J. Min, and J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658 (Pubitemid 36278583)
9. A. Venkatesha, M. Toporsian, and C. Lam Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649 (Pubitemid 43865232)
10. R. Levine, C. Lam, and C. Qian Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005 (Pubitemid 44343543)
11. R. Taylor, J. Grimwood, R. Taylor, M. McMaster, S. Fisher, and R. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 2003 177 182 (Pubitemid 36135616)
12. C. Buhimschi, E. Norwitz, and E. Funai Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia Am J Obstet Gynecol 192 2005 734 741 (Pubitemid 40311263)
13. R. Levine, S. Maynard, and C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 682
14. A. Wikstrom, A. Larsson, U. Eriksson, P. Nash, S. Norden-Lindeberg, and M. Olovsson Placental growth factor and soluble fms-like tyrosine kinase-1 in early-onset and late-onset preeclampsia Obstet Gynecol 109 2007 1368 1374 (Pubitemid 46869876)
15. R. Romero, J. Nien, and J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational neonate J Matern Fetal Neonatal Med 21 2008 9 23
16. A. Ohkuchi, C. Hirashima, and S. Matsubara Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia Hypertens Res 30 2007 151 159 (Pubitemid 46541789)
17. C. Redman, T. Lodge, H. Meacher, C. Marks, C. Simms, and I. Sargent Triage® PlGF test: point-of-care assay of plasma placental growth factor to diagnose preeclampsia Adv Perinatal Med 2010 Proceedings(ECPM):181-5
18. S. Verlohren, A. Galindo, and D. Schlembach An automated method for the determination of the sFlt-1/PlGF ratio in the assessment of preeclampsia Am J Obstet Gynecol 201 2009 e1 e11
19. F. Xie, Y. Hu, and S. Turvey Toll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and preeclampsia BJOG 117 2010 99 108
20. F. Xie, Y. Hu, and L.A. Magee An association between cytomegalovirus infection and preeclampsia: case-control study and data synthesis Acta Obstet Gynecol Scand 89 2010 1162 1167
21. F. Xie, Y. Hu, and D.P. Speert Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis Hypertens Pregnancy 29 2010 390 398
22. F. Xie, Y. Hu, and L.A. Magee Chlamydia pneumoniae infection in preeclampsia Hypertens Pregnancy 29 2010 468 477
23. L.A. Magee, M. Helewa, and J. Moutquin SOGC guidelines; diagnosis, evaluation and management of the hypertensive disorders of pregnancy J Obstet Gynaecol Can 30 suppl 2008 1 48
24. M. Kramer, R. Platt, S. Wen, K. Joseph, A. Allen, and M. Abrahamowicz A new and improved population-bases Canadian reference for birth weight for gestational age Pediatrics 108 2001 e35
25. M. Lindheimer, S. Taler, and F. Cunningham Hypertension in pregnancy J Am Hypertens 2 2008 484 494
26. P.M. Bossuyt, J.B. Reitsma, and D.E. Bruns Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative Clin Chem 49 2003 1 6 (Pubitemid 36078546)
27. A. Ohkuchi, C. Hirashima, and H. Suzuki Evaluation of a new and automated electrochemiluminescence immunassay for plasma sFtl-1 and PlGF levels in women with preeclampsia Hyperten Res 33 2010 422 427
28. G. Ogge, R. Romero, and J. Kusanovic Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice J Matern Fetal Neonatal Med 23 2010 820 827
29. H. Stepan, A. Unversucht, N. Wessel, and R. Faber Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion Hypertens 49 2007 818 824 (Pubitemid 351664216)